How should I order an epidural infusion of bupivacaine 0.125% combined with fentanyl 2 µg/mL?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Epidural Order Set for Bupivacaine 0.125% with Fentanyl 2 mcg/mL

For standard epidural labor analgesia, order bupivacaine 0.125% with fentanyl 2 mcg/mL as a continuous infusion at 8-12 mL/hour, or use patient-controlled epidural analgesia (PCEA) with a basal rate of 6 mL/hour, 5 mL bolus doses, and 10-minute lockout intervals. 1

Initial Dosing

After confirming proper epidural catheter placement with a test dose:

  • Loading dose: Administer 15-20 mL of bupivacaine 0.125% with fentanyl 2 mcg/mL 1, 2
  • This provides approximately 18.75-25 mg bupivacaine with 30-40 mcg fentanyl total
  • Administer incrementally in 3-5 mL aliquots with aspiration between doses to detect intravascular or intrathecal placement 3

Maintenance Regimens

Continuous Infusion (Most Common)

  • Rate: 8-12 mL/hour of bupivacaine 0.125% with fentanyl 2 mcg/mL 4, 5
  • This delivers 10-15 mg/hour bupivacaine with 16-24 mcg/hour fentanyl
  • Higher rates (10-12 mL/hour) provide longer duration before breakthrough pain but increase motor block 4

Patient-Controlled Epidural Analgesia (PCEA)

  • Basal infusion: 6 mL/hour 5
  • Demand bolus: 3-5 mL 1, 5
  • Lockout interval: 6-10 minutes 1, 5
  • Hourly maximum: 30 mL/hour 6
  • PCEA reduces total local anesthetic consumption by approximately 40% compared to continuous infusion while maintaining equivalent analgesia 5

Breakthrough Pain Management

If inadequate analgesia develops:

  1. First-line: Administer 5-10 mL bolus of the same solution (bupivacaine 0.125% with fentanyl 2 mcg/mL) 1
  2. If still inadequate: Give one additional 5-10 mL bolus
  3. If analgesia remains poor: Consider catheter malposition or migration—reassess catheter function and consider replacement 1

Critical caveat: Do not increase local anesthetic concentration for breakthrough pain, as this increases risk without proven benefit 1

Monitoring Requirements

Initial 15-30 Minutes After Loading

  • Blood pressure: Every 5 minutes for at least 15 minutes 1
  • Sensory level: Assess at 30 minutes to detect catheter malposition 1
  • Motor block: Use modified Bromage scale
  • Anesthesiologist should remain with patient for at least 10 minutes after initial bolus 1

Ongoing During Infusion

  • Blood pressure: Hourly if stable 1
  • Pain scores: Every 1-2 hours
  • Motor function: Assess ability to straight leg raise
  • Fetal heart rate: Continuous monitoring per obstetric protocols

Important Clinical Considerations

Motor Block Profile

Bupivacaine 0.125% produces incomplete motor block that allows ambulation in most patients 3. This concentration is specifically chosen to preserve motor function while providing adequate sensory analgesia. If complete motor block develops, suspect:

  • Intrathecal catheter migration
  • Subdural catheter placement
  • Excessive dosing

Comparison to Alternative Concentrations

The evidence shows that while bupivacaine 0.0625% with fentanyl 2 mcg/mL reduces motor block, it requires more frequent supplementation and provides shorter duration analgesia 4, 5. Conversely, bupivacaine 0.25% increases motor block without proportional analgesic benefit 4.

Bupivacaine 0.125% with fentanyl 2 mcg/mL represents the optimal balance between analgesia duration, motor preservation, and need for supplementation 1, 4.

Maximum Dosing Limits

  • Maximum bupivacaine: 400 mg per 24 hours 3
  • At 10 mL/hour of 0.125% solution, this equals 12.5 mg/hour or 300 mg/24 hours—well within safe limits
  • Repeat boluses: Can be given every 3 hours as needed 3

Common Pitfalls to Avoid

  1. Do not use bupivacaine 0.75% for obstetric epidural analgesia—this concentration is contraindicated in obstetrics due to cardiotoxicity risk 3

  2. Avoid rapid bolus injection of large volumes—always use incremental dosing with frequent aspiration 3

  3. Do not assume negative aspiration excludes intravascular placement—test doses with epinephrine (if not contraindicated) help detect intravascular injection 3

  4. Monitor for signs of local anesthetic systemic toxicity (LAST): Circumoral numbness, metallic taste, tinnitus, confusion, seizures, cardiovascular collapse

  5. Ensure IV access is established and functional before initiating epidural analgesia 3

Side Effect Management

  • Hypotension: Treat with IV fluids and phenylephrine or ephedrine as needed
  • Pruritus: More common with higher fentanyl doses; treat with diphenhydramine or low-dose naloxone if severe
  • Nausea/vomiting: Administer ondansetron 4-8 mg IV
  • Urinary retention: May require bladder catheterization

Equipment and Resuscitation Readiness

Have immediately available 3:

  • Oxygen and airway equipment
  • IV lipid emulsion (20%) for LAST treatment
  • Vasopressors (phenylephrine, ephedrine)
  • Benzodiazepines for seizure management
  • Advanced cardiac life support medications

This standardized order set for bupivacaine 0.125% with fentanyl 2 mcg/mL provides effective labor analgesia with minimal motor block, supported by both guideline recommendations 1 and FDA-approved dosing parameters 3.

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.